Biocryst Pharmaceuticals Inc (BCRX)
Working Capital Ratio
49.45%
Quarterly · Period ending:
BCRX Working Capital Ratio
Latest reported49.45%period ending
Latest reported49.45%period ending
BCRX Quarterly Working Capital Ratio (66.08% → 49.45%)
Quarterly working capital ratio
High-resolution chart · PNG
BCRX working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 49.4464% | |
| 38.3256% | |
| 40.5089% | |
| 37.0605% | |
| 48.405% | |
| 56.2699% | |
| 53.3388% | |
| 55.6857% | |
| 49.6153% | |
| 69.9262% | |
| 66.9255% | |
| 78.7309% | |
| 78.8016% | |
| 79.5952% | |
| 74.7247% | |
| 76.5071% | |
| 78.2435% | |
| 81.6147% | |
| 78.6223% | |
| 44.8275% | |
| 54.1687% | |
| 60.672% | |
| 65.1737% | |
| 28.7466% | |
| 47.1282% | |
| 24.0202% | |
| 41.0824% | |
| -3.7193% | |
| 27.3078% | |
| 36.0571% | |
| 30.5603% | |
| 38.1075% | |
| 13.5359% | |
| 18.5452% | |
| 28.3604% | |
| 55.4242% | |
| 29.3598% | |
| 42.4243% | |
| 14.0539% | |
| 14.3297% | |
| -12.2627% | |
| -12.2909% | |
| 1.234% | |
| 14.4348% | |
| 28.8425% | |
| 15.0184% | |
| 23.1278% | |
| 62.2213% | |
| 65.725% | |
| 50.8032% | |
| 54.9769% | |
| 63.2591% | |
| 54.0435% | |
| 51.3508% | |
| 43.0962% | |
| 53.0752% | |
| 51.7354% | |
| 45.9312% | |
| 32.3071% | |
| 57.6591% | |
| 53.4231% | |
| 64.0894% | |
| 54.4527% | |
| 62.4279% | |
| 55.6893% | |
| 57.5155% | |
| 51.8807% | |
| 54.3854% | |
| 67.9924% | |
| 71.027% | |
| 68.3854% | |
| 62.9606% | |
| 35.5544% | |
| 39.7339% | |
| 44.5547% | |
| 47.3426% | |
| 43.6985% | |
| 49.6334% | |
| 51.1862% | |
| 44.5822% | |
| 56.1227% | |
| 59.4645% | |
| 70.2463% | |
| 73.4726% | |
| 72.6079% | |
| 78.8559% | |
| 64.795% | |
| 53.4671% | |
| 54.2248% | |
| 58.4576% | |
| 64.3142% | |
| 59.0682% | |
| 69.3649% | |
| 58.7869% | |
| 58.2533% | |
| 61.1177% | |
| 55.0703% | |
| 53.4878% | |
| 51.4772% | |
| 49.0509% |